NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Complementary & Alternative Medicine



High-dose biotin may increase in guanylate cyclase activity and be diabetes therapy option



March 6th, 2006

CGMP may have trophic effects on beta cell function comparable to those of cAMP, and high-dose biotin may be an option for diabetes therapy.

According to recent research published in the journal Medical Hypotheses, "Incretin hormones have trophic effects on beta cell function that can aid prevention and treatment of diabetes. cAMP is the primary mediator of these effects, and has been shown to potentiate glucose-stimulated insulin secretion, promote proper beta cells differentiation by increasing expression of the crucial transcription factor PDX-1, and prevent beta cell apoptosis. cGMP's role in beta cell function has received far less scrutiny, but there is...


Source: Obesity & Diabetes Week (2006-03-06)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login